| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | 78 | 401 | 605 | 1.149 | 28.417 | 947 |
| Gross Profit/Loss - EUR | - | - | - | - | -78 | -401 | -605 | -1.149 | -28.417 | -947 |
| Net Profit/Loss - EUR | - | - | - | - | -78 | -401 | -605 | -1.149 | -28.417 | -947 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Force S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 371 | 0 | 0 | 0 | 998.897 | 993.314 |
| Current Assets | - | - | - | - | 59 | 57 | 56 | 56 | 99.609 | 98.493 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 99.060 | 98.506 |
| Cash | - | - | - | - | 59 | 57 | 56 | 56 | 549 | -13 |
| Shareholders Funds | - | - | - | - | -35 | -436 | -1.031 | -2.183 | -30.594 | -31.369 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 465 | 493 | 1.087 | 2.239 | 1.129.100 | 1.123.177 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharma Force S.r.l.